Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 19;18:1533033819874773. doi: 10.1177/1533033819874773

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Cytosolic nonspecific dipeptidase 2 (CNDP2) is highly expressed in ovarian cancer and indicates poor prognosis. A, The messenger RNA (mRNA) expression of CNDP2 in 19 cases of ovarian cancer and adjacent tissues. B, Low expression of normal tissues (negative staining) and high expression of ovarian cancer tissues (positive staining). C, Expression of CNDP2 in 100 cases with ovarian cancer and adjacent normal tissues. D, Expression of CNDP2 in metastatic and nonmetastatic ovarian cancer tissues. E, The survival curves of 34 low CNDP2 expression patients and 66 high CNDP2 expression patients. The CNDP2 immunohistochemical (IHC) staining scores for ovarian cancer tissues obtained from patients. **P < .01, ***P < .001, Mann-Whitney U test. Kaplan-Meier plots of the overall survival of patients with ovarian cancer based on CNDP2 high- or low-level expression.